IPO Market Booms in 2026 With $186.8 Billion Raised, but Top 10 Listings Fall 20.5%
The IPO market has delivered a paradox in 2026. Global proceeds more than tripled to $186.8 billion in the first half of 2026, up 201% from $62.1 billion a year earlier, according to EY. In the US, the 10 biggest initial public offerings have fallen 20.5% on average from their offer prices, according to FT analysis, the worst performance for large listings in at least four years.
The divergence matters for investors, bankers and companies planning to list. A booming market for issuance is not the same as a profitable market for buyers. As Anthropic prepares one of the largest listings in history, the gap between deal activity and aftermarket returns is becoming the defining story of the 2026 IPO cycle.
Key Takeaways
- Global IPO proceeds reached $186.8 billion in H1 2026, up 201% year-on-year, even as deal volume fell 12%.
- The 10 biggest US IPOs of 2026 have fallen 20.5% on average from their offer prices, per FT analysis.
- SpaceX, the year's largest listing, has traded near its $135 offer price after an initial pop.
- Anthropic is seeking a valuation of up to $1.4 trillion, selling 825 million shares at $70-$78.
- The US accounted for $130.3 billion of H1 proceeds, up 660% year-on-year, on just 84 deals.
- Eleven US IPOs each raised more than $1 billion in H1 2026, a sign of mega-deal concentration.
Why Are IPO Proceeds So High but Returns So Weak?
The first explanation is concentration. A small number of mega-deals have absorbed most of the capital. EY reports that 483 IPOs raised $186.8 billion globally in H1 2026, but the US alone accounted for $130.3 billion from just 84 listings. When a handful of deals dominate, the market's headline number says more about a few companies than about broad IPO health.
The second explanation is pricing. AI-related exuberance pushed offer prices high, leaving little room for post-listing gains. Sanjay Rijhsinghani, chief investment officer at LGT Wealth Management, told the FT: 'None of these IPOs are coming at bargain-basement prices.' When buyers pay for future growth that may not materialise, the aftermarket weakens.
The third explanation is supply. A wave of IPO issuance, follow-on equity raises and new debt from technology giants has saturated investor demand. Even a market with strong appetite can struggle to absorb that much paper at once.
IPO Market Data at a Glance
| Indicator | 2026 reading | Context |
|---|---|---|
| Global IPO proceeds, H1 2026 | $186.8 billion | Up 201% from $62.1 billion in H1 2025 |
| Global IPO deal count, H1 2026 | 483 deals | Down 12% year-on-year, despite higher proceeds |
| US IPO proceeds, H1 2026 | $130.3 billion | Up 660% from $17.2 billion, on 84 deals |
| Average return of 10 biggest US IPOs | −20.5% | From offer price, per FT analysis |
| SpaceX offer price | $135 per share | Largest IPO of 2026; trading near offer |
| Anthropic valuation target | Up to $1.4 trillion | 825 million shares at $70–$78 |
| US IPOs raising over $1 billion, H1 2026 | 11 deals | Mega-deal concentration |
How Does a Weak IPO Aftermarket Affect Investors?
For investors who bought the largest 2026 listings, the result has been disappointing. An investor who bought each of the 10 biggest Wall Street IPOs would be down more than 20% on average, a sharp contrast with the previous four years when the same strategy ended in positive territory. Even in 2022, when the S&P 500 fell 19.4%, IPO investors still made money.
The lesson is that IPO allocation is not a guaranteed path to returns. Lock-up expirations, insider selling and the sheer volume of new shares can pressure prices after listing. Some portfolio managers now prefer to wait for the secondary market rather than participate at the offer price, hoping to buy the same names cheaper later.
Will the Anthropic IPO Revive or Ruin the 2026 Market?
Anthropic is the next test. The AI company filed to sell 825 million shares at $70-$78, which would value it at up to $1.4 trillion. That would make it one of the largest listings ever, and a successful debut could restore confidence in the IPO pipeline.
But the timing is risky. Chip stocks sold off sharply in October 2026 on fears that AI infrastructure spending may not generate sufficient returns. The sell-off deepened after the US midterm elections in early November. Launching a mega-cap tech IPO into that backdrop is a gamble, even with strong investor demand.
What Should Companies and Investors Watch Next?
- Anthropic's pricing and first-day performance: a strong debut could reopen the window for other AI and tech listings.
- Lock-up expirations: shares from 2026 IPOs will become tradable, adding supply pressure.
- AI capital spending: if returns on AI infrastructure disappoint, IPO valuations will face a reckoning.
- Equity supply: follow-on raises and tech debt issuance could continue to absorb investor demand.
- IPO quality vs quantity: investors are rewarding profitable, reasonably valued companies and punishing speculative pricing.
Conclusion: A Boom for Bankers, a Bust for Buyers
The 2026 IPO market has raised more money than any year this decade, yet the biggest deals have lost investors more than 20% on average. That contradiction is the story. For investment banks, 2026 is a triumph. For public-market investors, it is a warning that issuance booms and returns do not always move together.
Anthropic's listing will determine whether the market can absorb another mega-deal without breaking. If it succeeds, the IPO window may stay open into 2027. If it stumbles, the gap between deal activity and aftermarket performance could define the next phase of the cycle.
Frequently Asked Questions (FAQ)
Why did IPO proceeds rise in 2026 while the number of deals fell?
Proceeds rose because a small number of very large listings, including SpaceX, absorbed most of the capital. Global proceeds reached $186.8 billion in H1 2026 even as deal volume fell 12% to 483 IPOs. The market became more concentrated in mega-deals.
How much have the biggest 2026 IPOs fallen?
The 10 biggest US IPOs of 2026 have fallen 20.5% on average from their offer prices, according to FT analysis. This is the worst performance for large listings in at least four years and contrasts with positive returns in 2022–2025.
Is the Anthropic IPO a good investment?
Anthropic is seeking a valuation of up to $1.4 trillion at $70–$78 per share, which is a very high price relative to current revenue. The IPO could perform well if AI demand holds, but the weak aftermarket for 2026 listings and the October tech sell-off make it a high-risk proposition.
What does weak IPO performance mean for companies planning to list?
Companies may face more scrutiny on valuation and may need to price deals more conservatively to attract investors. Bankers may also delay listings if the aftermarket remains weak. A successful Anthropic debut could reopen the window; a failed one could shut it.
Should investors buy IPOs or wait for the secondary market?
Given the 20.5% average decline in the biggest 2026 IPOs, some investors prefer to wait and buy in the secondary market at a lower price. IPO allocation can be profitable, but it requires careful valuation and awareness of lock-up and supply risks.